Infinity to Participate in Two Upcoming Conferences
Get Alerts INFI Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will participate in two upcoming investor conferences. On August 11, 2015, Infinity’s corporate presentation will be webcast live at the Wedbush PacGrow Life Sciences Conference in New York City. The webcast will be accessible on the “investors/media” section of the company's website, www.infi.com and will be available for 30 days following the event.
Infinity will also participate in the BMO Capital Markets Corporate Access Day in Boston, MA, on July 28, 2015. There will be no formal presentations or webcasting at this event.
About Infinity Pharmaceuticals, Inc.Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company’s website at www.infi.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150721005011/en/
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Senior
Investor Relations Associate,
Investor Relations and Corporate
Communications
[email protected]
Source: Infinity Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canon Adds Powerful Scanning Capabilities to its imagePROGRAF Printer Portfolio with Two WideTEK® Scanners from Image Access
- LogoTags Division of Ball Chain Manufacturing Co., Inc. Welcomes Fire Chief Dave Goldsmith as Independent Sales Representative
- Pacific Empire Announces Commencement of Mobile MagnetoTelluric Survey at Trident and Pinnacle
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!